Richter and Egis sell stakes in Medimpex

21 October 2007

Hungary's two leading Hungarian pharmaceutical manufacturers, Richter Gedeon and Egis, have sold their shares in wholesaler Medimpex. The companies each owned a 50% stake, and these are now to be taken over by the leading wholesaler Hungaropharma. Besides pharmacists and another manufacturer, Richter and Egis also own shares in Hungaropharma, reports Patrick Hollstein for ExpoPharm.

With a market share of 7%, Medimpex is the fourth largest wholesaler in Hungary behind Hungaropharma, Phoenix and Humantrade, which belongs to Israeli generics giant Teva. Medimpex owns Pannonmedicina, another wholesaler. According to a representative, the takeover of Medimpex by Hungaropharma has to be seen as an answer to the decreasing sales in the Hungarian pharmaceutical market.

It is not yet known if the merger also will result in a closure of warehouses and jobs cuts. The Hungarian pharmaceutical market declined by 9% as a result of various measures the government introduced to save money in the health care system (Marketletters passim).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight